Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease

Abdul, 2008, Oxidative damage in brain from humanmutant APP/PS-1doubleknock-in mice as a function of age, Free Radic Biol Med, 45, 1420, 10.1016/j.freeradbiomed.2008.08.012 Blurton-Jones, 2009, Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease, Proc Natl Acad Sci U S A, 106, 13594, 10.1073/pnas.0901402106 Butterfield, 2002, Lipid peroxidation and proteinoxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress, Free Radic Biol Med, 32, 1050, 10.1016/S0891-5849(02)00794-3 Butterfield, 2001, Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide, Trends Mol Med, 7, 548, 10.1016/S1471-4914(01)02173-6 Butterfield, 2010, In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid β-peptide of APP, Free Radic Biol Med, 48, 136, 10.1016/j.freeradbiomed.2009.10.035 Cancino, 2008, STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's β-amyloid deposits, Brain, 131, 2425, 10.1093/brain/awn125 Cenini, 2008, Effects of oxidative and nitrosative stress in brain on p53 pro-apoptotic protein in amnestic mild cognitive impairment and Alzheimer disease, Free Radic Biol Med, 45, 81, 10.1016/j.freeradbiomed.2008.03.015 Chauhan, 2006, Oxidative stress in Alzheimer'sdisease, Pathophysiology, 13, 195, 10.1016/j.pathophys.2006.05.004 Chen, 2007, Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck, Carcinogenesis, 128, 2008, 10.1093/carcin/bgm172 Choi, 2012, Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway, Neurochem Int, 60, 68, 10.1016/j.neuint.2011.11.005 Cotman, 1998, Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease, Neurobiol Aging, 19, S29, 10.1016/S0197-4580(98)00042-6 Cummings, 1996, β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease, Neurobiol Aging, 17, 921, 10.1016/S0197-4580(96)00170-4 D'Amelio, 2011, Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease, Nat Neurosci, 14, 69, 10.1038/nn.2709 Darvesh, 2012, Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease, J Neuropathol Exp Neurol, 17, 2, 10.1097/NEN.0b013e31823cc7a6 Dickson, 1995, Correlations of synaptic and pathological markers with cognition of the elderly, Neurobiol Aging, 16, 285, 10.1016/0197-4580(95)00013-5 Donovan, 2006, Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease, J Comp Neurol, 495, 70, 10.1002/cne.20840 Dyrks, 1992, Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation, J Biol Chem, 267, 18210, 10.1016/S0021-9258(19)37174-1 Eminel, 2004, JNK 2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine, J Biol Chem, 279, 55385, 10.1074/jbc.M405858200 Erickson, 2012, Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood–brain barrier: protection by the antioxidant N-acetylcysteine, Brain Behav Immun, 26, 1085, 10.1016/j.bbi.2012.07.003 Fan, 2007, Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid, J Neurosci, 27, 3057, 10.1523/JNEUROSCI.4371-06.2007 Funamoto, 2004, Truncated carboxyl-terminal fragments of β-Amyloid precursor protein are processed to amyloid β-proteins 40 and 42, Biochemistry, 43, 13532, 10.1021/bi049399k Giovannini, 2002, β-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38 MAPK pathway, Neurobiol Dis, 11, 257, 10.1006/nbdi.2002.0538 Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide, Mol Cell Biol, 8, 101 Hao, 2007, Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice, Pharmacol Biochem Behav, 86, 660, 10.1016/j.pbb.2007.02.011 Himeno, 2011, Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation, Ann Neurol, 69, 248, 10.1002/ana.22319 Ho, 2005, Mechanisms of cell signaling and inflammation in Alzheimer's disease, Curr Drug Targets Inflamm Allergy, 4, 247, 10.2174/1568010053586237 Hsia, 1999, Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models, Proc Natl Acad Sci U S A, 96, 3228, 10.1073/pnas.96.6.3228 Hu, 2005, A new approach to the pharmacological regulation of memory: sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models, Brain Res, 1060, 26, 10.1016/j.brainres.2005.08.019 Hu, 2010, Danggui–Shaoyao–San and its active fraction JD-30 improve Aβ-induced spatial recognition deficits in mice, J Ethnopharmacol, 128, 365, 10.1016/j.jep.2010.01.046 Hu, 2012, Schizandrin, an antioxidant lignan from Schisandra chinensis, ameliorates Aβ1–42-induced memory impairment inmice, Oxid Med Cell Longev, 2012, 1, 10.1155/2012/721721 Hynd, 2004, Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease, Neurochem Int, 45, 583, 10.1016/j.neuint.2004.03.007 Jang, 2002, β-amyloid induces oxidative DNA damage and cell death through activation of c-Jun N terminal kinase, Ann N Y Acad Sci, 973, 228, 10.1111/j.1749-6632.2002.tb04639.x Jhoo, 2004, β-Amyloid (1–42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex, Behav Brain Res, 155, 185, 10.1016/j.bbr.2004.04.012 Kalinin, 2012, The noradrenaline precursor l-DOPS reduces pathology in a mouse model of Alzheimer's disease, Neurobiol Aging, 33, 1651, 10.1016/j.neurobiolaging.2011.04.012 Katzman, 1991, Advances in Alzheimer's disease, FASEB J, 5, 278, 10.1096/fasebj.5.3.2001787 Kim, 2008, The effects of acute and repeated oroxylin A treatments on Aβ25–35-induced memory impairment in mice, Neuropharmacology, 55, 639, 10.1016/j.neuropharm.2008.05.019 Lee, 2008, Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation, J Neuroinflammation, 10.1186/1742-2094-5-37 Li, 1999, Protective effects of pseudoginsenoside-F11 on scopolamine-induced memory impairment in mice and rats, J Pharm Pharmacol, 51, 535, 10.1211/0022357991772484 Li, 2000, Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice, Pharmacol Biochem Behav, 66, 595, 10.1016/S0091-3057(00)00260-4 Loo, 1993, Apoptosis is induced by beta-amyloid in cultured central nervous system neurons, Proc Natl Acad Sci U S A, 90, 7951, 10.1073/pnas.90.17.7951 Łukawski, 2008, Effects of selective inhibition of N-acetylated-α-linked-acidic dipeptidase (NAALADase) on mice in learning and memory tasks, Eur J Pharmacol, 579, 202, 10.1016/j.ejphar.2007.10.032 Ma, 2011, Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response, Brain Res, 1400, 112, 10.1016/j.brainres.2011.05.030 Maezawa, 2011, Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity, J Biol Chem, 286, 3693, 10.1074/jbc.M110.135244 Maiese, 2004, Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease, Restor Neurol Neurosci, 22, 87 Marchalant, 2007, Anti-inflammatory property of the cannabinoid agonist Win-55215-2 in a rodent model of chronic brain inflammation, Neuroscience, 144, 1516, 10.1016/j.neuroscience.2006.11.016 Maurice, 1996, Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction, Brain Res, 706, 181, 10.1016/0006-8993(95)01032-7 Medeiros, 2007, Connecting TNF-α signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid β protein, J Neurosci, 27, 5394, 10.1523/JNEUROSCI.5047-06.2007 Misonou, 2000, Oxidative stress induces intracellular accumulation of amyloid β-protein (Aβ) in human neuroblastoma cells, Biochemistry, 39, 6951, 10.1021/bi000169p Montiel, 2006, Role of oxidative stress on β-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants, Exp Neurol, 200, 496, 10.1016/j.expneurol.2006.02.126 Papandreou, 2009, Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity, Behav Brain Res, 198, 352, 10.1016/j.bbr.2008.11.013 Paxinos, 2001 Pratico, 2001, Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis, J Neurosci, 21, 4183, 10.1523/JNEUROSCI.21-12-04183.2001 Reiserer, 2007, Impaired spatial learning in the APPSwe+PSEN1DE9 bigenic mouse model of Alzheimer's disease, Genes Brain Behav, 6, 54, 10.1111/j.1601-183X.2006.00221.x Rogers, 2011, CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity, J Neurosci, 31, 16241, 10.1523/JNEUROSCI.3667-11.2011 Salvesen, 1997, Caspases: intracellular signaling by proteolysis, Cell, 91, 443, 10.1016/S0092-8674(00)80430-4 Sambamurti, 2002, Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease, Neuromol Med, 1, 1, 10.1385/NMM:1:1:1 Saxena, 2008, Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice, Eur J Pharmacol, 581, 283, 10.1016/j.ejphar.2007.12.009 Schubert, 1995, Amyloid peptides are toxic via a common oxidative mechanism, Proc Natl Acad Sci U S A, 92, 1989, 10.1073/pnas.92.6.1989 Selkoe, 2000, Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta protein, Ann N Y Acad Sci, 924, 17, 10.1111/j.1749-6632.2000.tb05554.x Selkoe, 2008, Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior, Behav Brain Res, 192, 106, 10.1016/j.bbr.2008.02.016 Sherrin, 2010, Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning, J Neurosci, 30, 13348, 10.1523/JNEUROSCI.3492-10.2010 Sierksma, 2013, Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease, Neuropharmacology, 64, 124, 10.1016/j.neuropharm.2012.06.048 Smith, 2002, Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress, J Neurochem, 70, 2212, 10.1046/j.1471-4159.1998.70052212.x Stadelmann, 1999, Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease, Am J Pathol, 155, 1459, 10.1016/S0002-9440(10)65460-0 Sultana, 2010, Role of oxidative stress in the progression of Alzheimer's disease, J Alzheimers Dis, 19, 341, 10.3233/JAD-2010-1222 Tafolla, 2005, JNK 1 and JNK 2 oppositely regulate p53 in signaling linked to apoptosis triggered by an altered fibronectin matrix, J Biol Chem, 280, 19992, 10.1074/jbc.M500331200 Tamagno, 2005, β-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways, J Neurochem, 92, 628, 10.1111/j.1471-4159.2004.02895.x Tournier, 2000, Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway, Science, 288, 870, 10.1126/science.288.5467.870 Vickers, 2000, The cause of neuronal degeneration in Alzheimer's disease, Prog Neurobiol, 60, 139, 10.1016/S0301-0082(99)00023-4 Wang, 2011, Ginseng derivative ocotillol enhances neuronal activity through increased glutamate release: a possible mechanism underlying increased spontaneous locomotor activity of mice, Neuroscience, 195, 1, 10.1016/j.neuroscience.2011.08.002 Westerman, 2002, The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease, J Neurosci, 22, 1858, 10.1523/JNEUROSCI.22-05-01858.2002 Wu, 2003, Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice, Pharmacol Biochem Behav, 76, 103, 10.1016/S0091-3057(03)00215-6 Yan, 2001, Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid, Br J Pharmacol, 133, 89, 10.1038/sj.bjp.0704047 Yatin, 2000, Vitamin E prevents Alzheimer's amyloid β-peptide (1–42)-induced neuronal protein oxidation and reactive oxygen species production, J Alzheimers Dis, 2, 123, 10.3233/JAD-2000-2212 Yu, 2007, Cardioprotective effect of ocotillol, a derivate of pseudoginsenoside F11, on myocardial injury induced by isoproterenol in rats, Arzneimittelforschung, 57, 568 Zampagni, 2012, Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models, Free Radic Biol Med, 52, 1362, 10.1016/j.freeradbiomed.2012.01.012 Zhang, 2007, Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease, Exp Neurol, 204, 77, 10.1016/j.expneurol.2006.09.018 Zhang, 2008, Ginsenoside Rg1 protects neurons from hypoxic–ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels, Eur J Pharmacol, 586, 90, 10.1016/j.ejphar.2007.12.037 Zhang, 2012, Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction, Free Radic Biol Med, 52, 1443, 10.1016/j.freeradbiomed.2012.01.023 Zhao, 2009, Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondria, Mol Cell Neurosci, 41, 186, 10.1016/j.mcn.2009.02.012 Zhu, 2001, Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease, J Neurochem, 76, 435, 10.1046/j.1471-4159.2001.00046.x